Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Actavis strikes South Korean distribution deal

This article was originally published in Scrip

Executive Summary

Actavisis building up its presence in Asia through a new distribution agreement with the South Korean company J&M Pharma. The exclusive deal covers a number of products and marks the Icelandic generics firm's expansion into what it says is a fast-growing market. Actavis already sells its products in several countries in the Asia-Pacific region including China, Taiwan and Australia.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC022408

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel